background image

English

On-X

®

 Prosthetic Heart Valve | Instructions for Use 

17

Table 6: Operative Patient Demographics

Notes:
1.  Ordered by frequency of occurrence, except for valve size.
2.  n = number of patients in each category; N = total number of study patients.
3.  May be more than one per patient.

Operative Mitral Patient Demographics

All patients implanted, N = 229,  
Cumulative follow-up = 417.9 patient-years

Variable

Category

1

N

% (n/N)2

Etiology

3

Rheumatic

86

37.6%

Degenerative

62

27.1%

Calcific

36

15.7%

Endocarditis

16

7.0%

Prosthetic Valve Dysfunction

6

2.6%

Congenital

4

1.8%

Other

38

16.6%

Concomitant 
Procedures

3

None

130

56.8%

Coronary Artery Bypass Graft

44

19.2%

Tricuspid Repair

22

9.6%

Closure of Atrial Appendage

12

5.2%

Mitral Repair

12

5.2%

Maze Procedure

12

5.2%

Septal Defect Closure

8

3.5%

Ventricular Aneurysm Repair

3

1.3%

Muscularization

2

0.9%

Tricuspid Replacement

1

0.4%

Explant of Annuloplasty Ring

1

0.4%

Pre-existing 
Conditions

3

Atrial Arrhythmias

137

59.3%

Pulmonary Hypertension

108

46.8%

Systemic Hypertension

88

38.1%

Hyperlipidemia

88

38.1%

Congestive Heart Failure

80

34.6%

Other

77

33.3%

Coronary Artery Disease

67

29.0%

Cigarette Smoker

64

27.7%

Left Ventricular Dysfunction

47

20.4%

Cerebrovascular Accident

43

18.6%

Diabetes Mellitus

40

17.3%

Angina

38

16.4%

Myocardial Infarction

30

13.0%

Hyperthyriodism

27

11.7%

Chronic Obstructive Pulmonary Disease

25

10.8%

Endocarditis

18

7.8%

Gastroinestinal Ulcer

18

7.8%

Chronic Kidney Failure

13

5.6%

Carotid Artery Disease

12

5.2%

Coronary Artery Bypass Graft

10

4.4%

Cancer

10

4.4%

Previous Mitral Valve Replacement

9

3.9%

Cardiomyopathy

8

3.5%

Pacemaker Implant

6

2.6%

Valve Size

25 mm

33

14.4%

27/29 mm

131

57.2%

31/33 mm

65

28.4%

Operative Aortic Patient Demographics

All patients implanted, N = 184,  
Cumulative follow-up = 411.8 patient-years 

Variable

Category

1

n

% (n/N)2

Etiology

3

Calcific

92

50.0%

Degenerative

51

27.7%

Rheumatic

24

13.0%

Congenital

18

9.8%

Endocarditis

8

4.4%

Prosthetic Valve Dysfunction

0

0.0%

Other

6

3.3%

Concomitant 
Procedures

3

None

141

76.7%

Coronary Artery Bypass Graft

21

11.4%

Myotomy

10

5.4%

Mitral Repair

5

2.7%

Aorta Repair or Replacement

4

2.2%

Tricuspid Repair

1

0.5%

Muscle Bridge

1

0.5%

Tricuspid Replacement

0

0.0%

Explant of Annuloplasty Ring

0

0.0%

Maze Procedure

0

0.0%

Closure of Atrial Appendage

0

0.0%

Ventricular Aneurysm Repair

0

0.0%

Other

0

0.0%

Pre-existing 
Conditions

3

Systemic Hypertension

90

48.9%

Hyperlipidemia

83

45.1%

Angina

42

22.8%

Coronary Artery Disease

42

22.8%

Diabetes Mellitus

33

17.9%

Atrial Arrhythmias

25

13.6%

Left Ventricular Dysfunction

23

12.5%

Congestive Heart Failure

22

12.0%

Myocardial Infarction

12

6.5%

Cerebrovascular Accident

10

5.4%

Carotid Artery Disease

7

3.8%

Endocarditis

4

2.2%

Cardiomyopathy

3

1.6%

Pacemaker Implant

2

1.1%

Coronary Artery Bypass Graft

1

0.5%

Previous Aortic Valve Replacement

1

0.5%

Previous Mitral Valve Replacement

0

0.0%

Other

27

14.8%

Valve Size

19 mm

17

9.2%

21 mm

35

19.0%

23 mm

70

38.0%

25 mm

38

20.6%

27/29 mm

24

13.0%

Содержание On-X Aortic Heart Valve and Extended Holder

Страница 1: ...eart Valve with Conform X Sewing Ring REF ONXAC On X Mitral Heart Valve with Conform X Sewing Ring REF ONXMC On X Aortic Heart Valve with Anatomic Sewing Ring REF ONXAN On X Aortic Heart Valve and Ext...

Страница 2: ...SSMENT AND VALVE ROTATION 11 9 7 VALVE ORIENTATION 12 10 POSTOPERATIVE INFORMATION 12 10 1 MAGNETIC RESONANCE IMAGING MRI COMPATIBILITY 12 10 2 RETURNED GOODS 12 11 PATIENT INFORMATION 12 11 1 PATIENT...

Страница 3: ...eplica sizers verify the aortic valve 10 Figure 12 Supra annular valve positioning 11 Figure 13 Sewing ring cross sections 11 Figure 14 Removing the valve holder 11 Figure 15 Insert valve rotator 12 F...

Страница 4: ...a travel arc of 50 to the closed position The orifice is composed of graphite substrate coated with On X Carbon a pure unalloyed form of pyrolytic carbon The leaflets consist of On X Carbon deposited...

Страница 5: ...esis regurgitation prosthesis structural dysfunction prosthesis thrombosis stroke thromboembolism It is possible that these complications could lead to reoperation explantation permanent disability de...

Страница 6: ...rded on the outer package label Appropriate inventory control should be maintained so that prostheses with earlier expiration dates are preferentially implanted and expiration is avoided To protect th...

Страница 7: ...YES Intrasupra annular 23 Aortic Cylindrical YES Intrasupra annular 25 Aortic Cylindrical YES Intrasupra annular 27 29 Aortic Conical YES Intra annular 19 Aortic Conform X Cylindrical YES Intrasupra...

Страница 8: ...n and Resterilization The On X Prosthetic Heart Valve is provided sterile If the sterility expiration date has passed or if upon removal from the outer box the valve container is damaged or the steril...

Страница 9: ...the patient or place it in the patient s records Figure 7a Twist off outer lid Figure 7b Remove by pull tab Figure 7c or invert on sterile field 4 Open the outer container Twist off outer lid package...

Страница 10: ...thetic Heart Valve sizers when sizing the annulus Sizers contain cylindrical conical and aortic replica ends Refer to Table 2 to facilitate sizer selection Cylindrical sizers correspond to the valve s...

Страница 11: ...mplanted using a pledgetted or non pledgetted everting mattress suture technique although non everting and continuous suture techniques have also been used with success CAUTION When seating the valve...

Страница 12: ...e to rotation is encountered The torque required to rotate the valve in situ should be about the same as that required when testing rotation before implantation If noticeably greater torque is require...

Страница 13: ...mplete the card and carry it with them at all times 11 3 Patient Information Booklet On XLTI has made available a patient information booklet that the physician may choose to provide to the patient pr...

Страница 14: ...s in an international multicenter prospective non randomized study with retrospective controls Patients requiring isolated mitral heart valve replacement were enrolled from 1996 to 2001 at 16 centers...

Страница 15: ...d as linearized rates based on total patient years 3 Freedom from event was calculated based on the method of Kaplan Meier SE Standard Error 4 n number of patients in each category N total number of s...

Страница 16: ...3 0 7 99 0 0 7 99 0 0 7 Explant 1 0 4 3 0 7 98 0 1 0 98 0 1 0 Hemolysis5 0 0 0 0 0 0 100 0 0 100 0 0 Hemorrhage6 all 4 1 8 6 1 4 96 4 1 3 94 4 2 0 Hemorrhage major 4 1 8 2 0 5 97 0 1 2 97 0 1 2 Periv...

Страница 17: ...tis 18 7 8 Gastroinestinal Ulcer 18 7 8 Chronic Kidney Failure 13 5 6 Carotid Artery Disease 12 5 2 Coronary Artery Bypass Graft 10 4 4 Cancer 10 4 4 Previous Mitral Valve Replacement 9 3 9 Cardiomyop...

Страница 18: ...ts followed reproduced from Figure 2 Nd number of patients for which NYHA data were collected not including missing 3 n number of patients in each category 4 Undetermined means data were collected but...

Страница 19: ...2 0 4 3 Regurgitation Nd 20 Nd 37 Nd 68 Nd 36 Nd 25 n n Nd n n Nd n n Nd N n Nd n n Nd 0 5 25 0 9 24 3 27 39 7 17 47 2 7 28 0 1 2 12 60 0 25 67 6 37 54 4 16 44 4 17 68 0 3 2 10 0 0 0 0 3 4 4 2 5 6 1 4...

Страница 20: ...Bldg B Austin Texas 78752 U S A TEL 512 339 8000 FAX 512 339 3636 WEB www onxlti com EMAIL onx onxlti com CryoLife Europa Ltd Bramley House The Guildway Old Portsmouth Road Guildford Surrey GU3 1LR Un...

Отзывы: